MONTREAL—A decade after contracting acute diarrheal illness from infection with Escherichia coli 0157:H7, individuals are at increased risk for definite renal impairment with microalbuminuria, hypertension, and cardiovascular events compared with individuals not infected with the pathogen.

ORLANDO, Fla.—Acute kidney injury (AKI), acute renal failure , and the need for dialysis are common complications in critically ill patients with pandemic H1N1 Influenza A (pH1N1), and are associated with an increased risk of death, according to Canadian researchers.

NEW ORLEANS—Acute renal failure (ARF) induced by pathogenic light chains can be the first presenting sign of multiple myeloma, and prompt treatment of the malignancy is critical to reversing renal damage, according to a study presented by European investigators at the American Society of Hematology 51st annual meeting.

Acute renal damage may resolve in the absence of the underlying cause.

They are less likely than men to suffer acute renal failure and other complications, researchers say.

Researcher Macaulay Onuigbo, MD, MSc, proposes that ACE inhibitors and angiotensin receptor blockers can cause renal failure.

ORLANDO—Acute renal failure (ARF) may be more likely to develop following coronary artery bypass grafting (CABG) than percutaneous coronary intervention (PCI), according to researchers.

THE FDA is recommending that only prescription oral sodium phosphate (OSP) bowel preparations be used by patients for bowel cleansing prior to undergoing colonoscopy. The agency also is requiring "black box" warnings on these products.

In a seemingly paradoxical manner, observational studies examining outcomes in patients suffering from CKD have found significantly altered risk-factor patterns such that conventional mortality risk factors have been associated with better survival; this phenomenon was termed "reverse epidemiology" or "risk factor paradox."

Ferumoxytol, a novel, semi-synthetic, superparamagnetic iron oxide nanoparticle administered by injection, is well tolerated and has a safety profile similar to placebo in CKD patients with anemia, according to a report in the American Journal of Kidney Diseases.